BAY65-1942 is a novel, potent and selective ATP-competitive inhibitor of IKKβ.

INH14 is a novel, potent and cell permeable inhibitor of IKKα/IKKβ, with IC50s of 8.97 and 3.59 μM, respectively.

Bardoxolone Methyl (also called NSC 713200; NSC-713200; RTA 402; RTA-402 and CDDO-methyl ester) is a novel, potent, orally bioavailable IKK inhibitor, showing potent proapoptotic and anti-inflammatory activities.

Bay 65-1942 R-isomer is the R-enantiomeric isomer of BAY65-1942 which is a novel, potent and selective ATP-competitive inhibitor of IKKβ.

MLN120B (MLN-120B) is a novel, potent, specific and ATP competitive IKKβ (IκB kinase beta subunit) inhibitor with anti-inflammatory activity.

Dehydrocostus Lactone is a novel and potent sesquiterpene.

PS-1145 (PS1145) is a novel, potent and specific IKK (IκB kinase) inhibitor with anticancer activity.

BMS-345541 HCl is a novel, cell-permeable and selective inhibitor of the catalytic subunits of IKK-2 and IKK-1 with IC50 of 0.3 μM and 4 μM in cell-free assays, respectively.